<?xml version="1.0" encoding="UTF-8"?>
<p>Random-amplification deep-sequencing approaches played a critical role in identifying MERS-CoV and SARS-CoV-2 [
 <xref rid="CIT0006" ref-type="bibr">6</xref>,
 <xref rid="CIT0011" ref-type="bibr">11</xref>,
 <xref rid="CIT0043" ref-type="bibr">43–47</xref>]. For the clinical diagnostic application, the genetic heterogeneity of HCoVs precludes a single “pan-HCoV” molecular assay [
 <xref rid="CIT0048" ref-type="bibr">48–51</xref>] (
 <xref rid="T0002" ref-type="table">Table 2</xref>). Some pan-CoV assays use degenerate primers [
 <xref rid="CIT0052" ref-type="bibr">52</xref>], some utilize multiple primer sets [
 <xref rid="CIT0053" ref-type="bibr">53</xref>], and others employ a single set of nondegenerate primers [
 <xref rid="CIT0054" ref-type="bibr">54</xref>]. Current molecular respiratory panels that detect the endemic HCoVs (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and HCoV-229E) require multiple sets of PCR oligonucleotides [
 <xref rid="CIT0012" ref-type="bibr">12</xref>,
 <xref rid="CIT0055" ref-type="bibr">55–57</xref>]. SARS-CoV-2 cases tested negative for endemic HCoVs included in molecular respiratory panels [
 <xref rid="CIT0010" ref-type="bibr">10</xref>].
</p>
